News

A different study presented at the 2025 ASCO Annual Meeting showed that one specific diet may benefit people with colon ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...
The biologic and biosimilar era has brought about more clinical trials in rheumatology than ever before, and with increasing ...